Panacela Labs panacelalabs.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Panacela Labs, founded in 2011, is a clinical stage biotechnology company. The company is a majority-owned joint venture of Cleveland BioLabs. Panacela's lead development program is Mobilan, a nanoparticle-formulated, recombinant non-replicating adenovirus in clinical development as a cancer therapy.

Panacela Labs, founded in 2011, is a clinical stage biotechnology company. The company is a majority-owned joint venture of Cleveland BioLabs. Panacela's lead development program is Mobilan, a nanoparticle-formulated, recombinant non-replicating aden...Show all

Company (Alive / Active)

Phone: 716-849-6810

Fax:

73 High Street

Buffalo, 14203
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Panacela Labs $39.9M Dec 22, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Panacela Labs Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
RusnanoGovernmentRussian FederationRecap, Series A
Cleveland BioLabsCorporationBuffalo, New York, United StatesRecap, Series A
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Small molecules inhibiting oncoprotein myc Oct 14, 2013 Jul 12, 2016 Patent
Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist Oct 06, 2010 Dec 08, 2015 Patent
Method for treating androgen receptor positive cancers Oct 25, 2010 Sep 16, 2014 Patent
Compounds and methods for treating cancers Mar 14, 2014 Application